Cited by 394Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Does corticobasal degeneration exist? A clinicopathological re-evaluation

Ling, H., O'Sullivan, S. S., Holton, J. L., Revesz, T., Massey, L. A., Williams, D. R., Paviour, D. C., Lees, A. J.·2010·Brain

DOI 10.1093/brain/awq123

Open this paper in CoChat — free account

Abstract

The pathological findings of corticobasal degeneration are associated with several distinct clinical syndromes, and the corticobasal syndrome has been linked with a number of diverse pathologies. We have reviewed all the archival cases in the Queen Square Brain Bank for Neurological Disorders over a 20-year period with either a clinical diagnosis of corticobasal syndrome or pathological diagnosis of corticobasal degeneration in an attempt to identify the main diagnostic pitfalls. Of 19 pathologically confirmed corticobasal degeneration cases, only five had been diagnosed correctly in life (sensitivity=26.3%) and four of these had received an alternative earlier diagnosis. All five of these had a unilateral presentation, clumsy useless limb, limb apraxia and myoclonus, four had cortical sensory impairment and focal limb dystonia and three had an alien limb. Eight cases of corticobasal degeneration had been clinically diagnosed as progressive supranuclear palsy, all of whom had vertical supranuclear palsy and seven had falls within the first 2 years. On the other hand, of 21 cases with a clinical diagnosis of corticobasal syndrome, only five had corticobasal degeneration pathology, giving a positive predictive value of 23.8%; six others had progressive supranuclear palsy pathology, five had Alzheimer's disease and the remaining five had other non-tau pathologies. Corticobasal degeneration can present very commonly with a clinical picture closely resembling classical progressive…

Integrity signals

Registry

Crossref · 10.1093/brain/awq123

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Case 39-2000
Rochester, C. L., & Kradin, R. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432509 · Cited by 3,875
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop*
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Greenfield's Neuropathology
(1964) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,411
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Hughes, A. J., Daniel, S. E., Ben‐Shlomo, Y., & Lees, A. J. (2002) · Brain · doi:10.1093/brain/awf080 · Cited by 1,258
Self-citation
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
Case 34-1990
Cabot, R. C., Scully, R. E., Mark, E. J., McNeely, W. F., McNeely, B. U., Harris, W. H., & Rosenberg, A. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230808 · Cited by 896
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A. M., Watt, H., Kilford, L., Holton, J. L., Révész, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 747
Self-citation
Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
Dickson, D. W., Bergeron, C., Chin, S. S., Duyckaerts, C., Horoupian, D., Ikeda, K., Jellinger, K., Lantos, P. L., Lippa, C. F., Mirra, S. S., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.935 · Cited by 724
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech
Josephs, K. A. (2006) · Brain · doi:10.1093/brain/awl078 · Cited by 698

Show all 63 references

Research works printed but not linked: 7

1999, Journal of neurology, 246, II6
Geda, 2007, Journal of Neuropsychiatry and Clinical Neurosciences, 19, 77, 10.1176/appi.neuropsych.19.1.77 · DOI
2007, Revista de neurologia, 163, 1191
1925, Revue neurologique, 2, 586
2010, Acta neuropathologica, 119, 365, 10.1007/s00401-009-0605-1 · DOI
Vidailhet, 2000, Advances in neurology, 82, 161
1985, Neurology, 35, 178

Sorted by citations

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., et al. (2017) · Movement Disorders · doi:10.1002/mds.26987 · Cited by 2,434
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Mollenhauer, B., Locascio, J. J., Schulz‐Schaeffer, W., Sixel‐Döring, F., Trenkwalder, C., & Schlossmacher, M. G. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70014-x · Cited by 636
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Boxer, A. L., Yu, J.-T., Golbe, L. I., Litvan, I., Lang, A. E., & Höglinger, G. U. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30157-6 · Cited by 485
Neuropathological background of phenotypical variability in frontotemporal dementia
Josephs, K. A., Hodges, J. R., Snowden, J. S., Mackenzie, I. R., Neumann, M., Mann, D. M. A., & Dickson, D. W. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0839-6 · Cited by 475
Clinicopathological correlations in corticobasal degeneration
Lee, S. E., Rabinovici, G. D., Mayo, M. C., Wilson, S. M., Seeley, W. W., DeArmond, S. J., Huang, E. J., Trojanowski, J. Q., Growdon, M. E., Jang, J. Y., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22424 · Cited by 434
Frontotemporal dementia
Olney, N. T., Spina, S., & Miller, B. L. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.008 · Cited by 419
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech
Josephs, K. A., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Master, A. V., Lowe, V. J., Jack, C. R., & Whitwell, J. L. (2012) · Brain · doi:10.1093/brain/aws032 · Cited by 425
Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)
Dickson, D. W., Kouri, N., Murray, M. E., & Josephs, K. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9589-0 · Cited by 380
Eye movements in patients with neurodegenerative disorders
Anderson, T., & MacAskill, M. R. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.273 · Cited by 376
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration
Rohrer, J. D., Lashley, T., Schott, J. M., Warren, J. D., Mead, S., Isaacs, A. M., Beck, J. A., Hardy, J., de Silva, R., Warrington, E. K., et al. (2011) · Brain · doi:10.1093/brain/awr198 · Cited by 370
Self-citation
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
Schoonenboom, N. S. M., Reesink, F. E., Verwey, N. A., Kester, M. I., Teunissen, C. E., van de Ven, P. M., Pijnenburg, Y. A. L., Blankenstein, M. A., Rozemuller, A. J., Scheltens, P., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31823ed0f0 · Cited by 302
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
Magdalinou, N. K., Paterson, R. W., Schott, J. M., Fox, N. C., Mummery, C. J., Blennow, K., Bhatia, K. P., Morris, H. R., Giunti, P., Warner, T. T., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309562 · Cited by 254
Self-citation
Corticobasal degeneration: a pathologically distinct 4R tauopathy
Kouri, N., Whitwell, J. L., Josephs, K. A., Rademakers, R., & Dickson, D. W. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.43 · Cited by 246
18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
Meyer, P. T., Frings, L., Rücker, G., & Hellwig, S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.186403 · Cited by 248
The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships
Snowden, J. S., Thompson, J. C., Stopford, C. L., Richardson, A. M. T., Gerhard, A., Neary, D., & Mann, D. M. A. (2011) · Brain · doi:10.1093/brain/awr189 · Cited by 256
Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias
Murray, M. E., Kouri, N., Lin, W.-L., Jack, C. R., Dickson, D. W., & Vemuri, P. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt231 · Cited by 249
Four-repeat tauopathies
Rösler, T. W., Marvian, A. T., Brendel, M., Nykänen, N.-P., Höllerhage, M., Schwarz, S. C., Hopfner, F., Koeglsperger, T., Respondek, G., Schweyer, K., et al. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101644 · Cited by 231
Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations
Lashley, T., Rohrer, J. D., Mead, S., & Révész, T. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12250 · Cited by 234
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
Kouri, N., Ross, O. A., Dombroski, B., Younkin, C. S., Serie, D. J., Soto-Ortolaza, A., Baker, M., Finch, N. C. A., Yoon, H., Kim, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8247 · Cited by 219
The Differential Diagnosis and Treatment of Atypical Parkinsonism
Levin, J., Kurz, A., Arzberger, T., Giese, A., & Höglinger, G. U. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0061 · Cited by 235
Diagnostic criteria for corticobasal syndrome: a comparative study
Mathew, R., Bak, T. H., & Hodges, J. R. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300875 · Cited by 200
CSF biomarkers cutoffs: The importance of coincident neuropathological diseases
Toledo, J. B., Brettschneider, J., Grossman, M., Arnold, S. E., Hu, W. T., Xie, S. X., Lee, V. M.-Y., Shaw, L. M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0983-7 · Cited by 182
Cognition in corticobasal syndrome and progressive supranuclear palsy: A review
Burrell, J. R., Hodges, J. R., & Rowe, J. B. (2014) · Movement Disorders · doi:10.1002/mds.25872 · Cited by 185
Optical Coherence Tomography in Parkinsonian Syndromes
Albrecht, P., Müller, A., Südmeyer, M., Ferrea, S., Ringelstein, M., Cohn, E., Aktaş, O., Dietlein, T. S., Lappas, A., Foerster, A. M. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034891 · Cited by 179
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
Jabbari, E., Holland, N., Chelban, V., Jones, P. S., Lamb, R., Rawlinson, C. V., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4347 · Cited by 187
Self-citation
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease
Ling, H., Massey, L. A., Lees, A. J., Brown, P., & Day, B. L. (2012) · Brain · doi:10.1093/brain/aws038 · Cited by 177
Self-citation
[ 18 F]FDG-PET is superior to [ 123 I]IBZM-SPECT for the differential diagnosis of parkinsonism
Hellwig, S., Amtage, F., Kreft, A., Buchert, R., Winz, O., Vach, W., Spehl, T. S., Rijntjes, M., Hellwig, B., Weiller, C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b0a · Cited by 175
Validation of the new consensus criteria for the diagnosis of corticobasal degeneration
Alexander, S., Rittman, T., Xuereb, J. H., Bak, T. H., Hodges, J. R., & Rowe, J. B. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307035 · Cited by 174
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Respondek, G., Kurz, C., Arzberger, T., Compta, Y., Englund, E. M., Ferguson, L. W., Gelpí, E., Giese, A., Irwin, D. J., Meissner, W. G., et al. (2017) · Movement Disorders · doi:10.1002/mds.27034 · Cited by 170
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
Tsai, R. M., Bejanin, A., Lesman-Segev, O., LaJoie, R., Visani, A., Bourakova, V., O’Neil, J. P., Janabi, M., Baker, S., Lee, S. E., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0470-7 · Cited by 164
Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease
Balasa, M., Gelpí, E., Antonell, A., Rey, M. J., Sánchez‐Valle, R., Molinuevo, J. L., & Lladó, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31821a44dd · Cited by 157
The Disturbance of Gaze in Progressive Supranuclear Palsy: Implications for Pathogenesis
Chen, A. L., Riley, D. E., King, S. A., Joshi, A. C., Serra, A., Liao, K., Cohen, M. L., Otero‐Millan, J., Martínez‐Conde, S., Strupp, M. L., et al. (2010) · Frontiers in Neurology · doi:10.3389/fneur.2010.00147 · Cited by 147
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
Forrest, S. L., Kril, J. J., Stevens, C. H., Kwok, J. B., Hallupp, M., Kim, W. S., Huang, Y. M., McGinley, C. V., Werka, H., Kiernan, M. C., et al. (2017) · Brain · doi:10.1093/brain/awx328 · Cited by 156
Therapy and clinical trials in frontotemporal dementia: past, present, and future
Tsai, R. M., & Boxer, A. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13640 · Cited by 157
Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies
Stamelou, M., Respondek, G., Giagkou, N., Whitwell, J. L., Kovács, G. G., & Höglinger, G. U. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00541-5 · Cited by 149
Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology
Ling, H., Kovács, G. G., Vonsattel, J. P., Davey, K., Mok, K. Y., Hardy, J., Morris, H. R., Warner, T. T., Holton, J. L., & Révész, T. (2016) · Brain · doi:10.1093/brain/aww256 · Cited by 136
Self-citation
Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome
Kouri, N., Murray, M. E., Hassan, A., Rademakers, R., Uitti, R. J., Boeve, B. F., Graff‐Radford, N. R., Wszołek, Z. K., Litvan, I., Josephs, K. A., et al. (2011) · Brain · doi:10.1093/brain/awr234 · Cited by 137
A disease-specific metabolic brain network associated with corticobasal degeneration
Niethammer, M., Tang, C. C., Feigin, A., Allen, P. J., Heinen, L., Hellwig, S., Amtage, F., Hanspal, E. K., Vonsattel, J. P., Poston, K. L., et al. (2014) · Brain · doi:10.1093/brain/awu256 · Cited by 130
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease
Haggerty, T., Credle, J. J., Rodriguez, O. C., Wills, J., Oaks, A. W., Masliah, E., & Sidhu, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07660.x · Cited by 126
“Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide
Stamelou, M., Quinn, N. P., & Bhatia, K. P. (2013) · Movement Disorders · doi:10.1002/mds.25509 · Cited by 122
Parkinsonian Syndromes
Williams, D. R., & Litvan, I. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000436152.24038.e0 · Cited by 132
Self-citation
Parkinsonism, movement disorders and genetics in frontotemporal dementia
Baizabal-Carvallo, J. F., & Jankovic, J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.14 · Cited by 121
In vivo retention of 18 F-AV-1451 in corticobasal syndrome
Smith, R., Schöll, M., Widner, H., van Westen, D., Svenningsson, P., Hägerström, D., Ohlsson, T., Jögi, J., Nilsson, C., & Hansson, O. (2017) · Neurology · doi:10.1212/wnl.0000000000004264 · Cited by 117
The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
Rittman, T., Ghosh, B. C. P., McColgan, P., Breen, D. P., Evans, J., Williams‐Gray, C. H., Barker, R., & Rowe, J. B. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303618 · Cited by 114
Progressive supranuclear palsy: Advances in diagnosis and management
Coughlin, D. G., & Litvan, I. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.04.014 · Cited by 118
Neuropathology and emerging biomarkers in corticobasal syndrome
Koga, S., Josephs, K. A., Aiba, I., Yoshida, M., & Dickson, D. W. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-328586 · Cited by 115
Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration
Yoshida, M. (2014) · Neuropathology · doi:10.1111/neup.12143 · Cited by 107
Degradation of emotion processing ability in corticobasal syndrome and Alzheimer’s disease
Kumfor, F., Sapey‐Triomphe, L., Leyton, C. E., Burrell, J. R., Hodges, J. R., & Piguet, O. (2014) · Brain · doi:10.1093/brain/awu246 · Cited by 107
Corticobasal degeneration and corticobasal syndrome: A review
Constantinides, V. C., Paraskevas, G. P., Paraskevas, P. G., Stefanis, L., & Kapaki, E. N. (2019) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2019.08.005 · Cited by 113
CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders
Mondello, S., Constantinescu, R., Zetterberg, H., Andréasson, U., Holmberg, B., & Jeromin, A. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.01.011 · Cited by 100
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
Lamb, R., Rohrer, J. D., Lees, A. J., & Morris, H. R. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0422-5 · Cited by 100
Self-citation
Dopamine transporter imaging in autopsy‐confirmed Parkinson's disease and multiple system atrophy
Perju‐Dumbrava, L., Kovács, G. G., Pirker, S., Jellinger, K. A., Hoffmann, M., Asenbaum, S., & Pirker, W. (2011) · Movement Disorders · doi:10.1002/mds.24000 · Cited by 93
Clinical Approach to Progressive Supranuclear Palsy
Ling, H. (2016) · Journal of Movement Disorders · doi:10.14802/jmd.15060 · Cited by 96
Self-citation
Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
Cilia, R., Rossi, C. A., Frosini, D., Volterrani, D., Siri, C., Pagni, C., Benti, R., Pezzoli, G., Bonuccelli, U., Antonini, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018301 · Cited by 92
Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant
Ling, H., de Silva, R., Massey, L. A., Courtney, R. J., Hondhamuni, G., Bajaj, N. P. S., Lowe, J. S., Holton, J. L., Lees, A. J., & Révész, T. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12037 · Cited by 97
Self-citation
A peculiar constellation of tau pathology defines a subset of dementia in the elderly
Kovács, G. G., Molnár, K., László, L., Ströbel, T., Botond, G., Hönigschnabl, S., Reiner‐Concin, A., Palkovits, M., Fischer, P. A., & Budka, H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0819-x · Cited by 90
Milestones in atypical and secondary Parkinsonisms
Wenning, G. K., Litvan, I., & TOLOSA, E. S. (2011) · Movement Disorders · doi:10.1002/mds.23713 · Cited by 88
Molecular imaging in dementia: Past, present, and future
Laforce, R. J., Soucy, J., Sellami, L., Dallaire‐Théroux, C., Brunet, F., Bergeron, D., Miller, B. L., & Ossenkoppele, R. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2855 · Cited by 88
Cortical [ 18 F ] PI ‐2620 Binding Differentiates Corticobasal Syndrome Subtypes
Palleis, C., Brendel, M., Finze, A., Weidinger, E., Bötzel, K., Danek, A., Beyer, L., Nitschmann, A., Kern, M., Biechele, G., et al. (2021) · Movement Disorders · doi:10.1002/mds.28624 · Cited by 87
The Multiple Phenotypes of Corticobasal Syndrome and Corticobasal Degeneration: Implications for Further Study
Boeve, B. F. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9624-1 · Cited by 84
Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes
Garraux, G., Phillips, C. L. M., Schrouff, J., Kreisler, A., Lemaire, C. F., Degueldre, C., Delcour, C., Hustinx, R., Luxen, A., Destée, A., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.06.004 · Cited by 83
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
Bluett, B., Pantelyat, A. Y., Litvan, I., Ali, F., Apetauerova, D., Bega, D., Bloom, L., Bower, J. H., Boxer, A. L., Dale, M. L., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.694872 · Cited by 92
Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau
Josephs, K. A. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.04.016 · Cited by 87
CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes
Constantinides, V. C., Paraskevas, G. P., Emmanouilidou, E., Petropoulou, O., Bougea, A. M., Vekrellis, K., Evdokimidis, I., Stamboulis, E., & Kapaki, E. N. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.09.039 · Cited by 83
Language impairment in progressive supranuclear palsy and corticobasal syndrome
Peterson, K. A., Patterson, K. E., & Rowe, J. B. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09463-1 · Cited by 84
The corticobasal syndrome–Alzheimer’s disease conundrum
Hassan, A., Whitwell, J. L., & Josephs, K. A. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.153 · Cited by 80
Structural brain imaging in frontotemporal dementia
Rohrer, J. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.014 · Cited by 86
Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications
Laforce, R., & Rabinovici, G. D. (2011) · Alzheimer's Research & Therapy · doi:10.1186/alzrt93 · Cited by 79
Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype
Koga, S., Kouri, N., Walton, R. L., Ebbert, M., Josephs, K. A., Litvan, I., Graff‐Radford, N. R., Ahlskog, J. E., Uitti, R. J., van Gerpen, J. A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1878-z · Cited by 82
Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat Tauopathies
Respondek, G., Grimm, M., Piot, I., Arzberger, T., Compta, Y., Englund, E. M., Ferguson, L. W., Gelpí, E., Roeber, S., Giese, A., et al. (2019) · Movement Disorders · doi:10.1002/mds.27872 · Cited by 79
Eye Movement Disorders in Movement Disorders
Kassavetis, P., Kaski, D. N., Anderson, T., & Hallett, M. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13413 · Cited by 72
Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes
Whitwell, J. L., Schwarz, C. G., Reid, R. I., Kantarci, K., Jack, C. R., & Josephs, K. A. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.01.023 · Cited by 66
Dystonia in corticobasal degeneration: A review of the literature on 404 pathologically proven cases
Stamelou, M., Cánovas, A. A., & Bhatia, K. P. (2012) · Movement Disorders · doi:10.1002/mds.24992 · Cited by 68
Clinical Spectrum of Tauopathies
Olfati, N., Shoeibi, A., & Litvan, I. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.944806 · Cited by 66
Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration
Seo, S. W., Thibodeau, M., Perry, D. C., Hua, A. Y., Sidhu, M., Sible, I. J., Vargas, J. N. S., Gaus, S. E., Rabinovici, G. D., Rankin, K. D., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005163 · Cited by 67
Pathology and sensitivity of current clinical criteria in corticobasal syndrome
Ouchi, H., Toyoshima, Y., Tada, M., Oyake, M., Aida, I., Tomita, I., Satoh, A., Tsujihata, M., Takahashi, H., Nishizawa, M., et al. (2013) · Movement Disorders · doi:10.1002/mds.25746 · Cited by 67
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Baldacci, F., Mazzucchi, S., Vecchia, A. D., Giampietri, L., Giannini, N., Koronyo‐Hamaoui, M., Ceravolo, R., Siciliano, G., Bonuccelli, U., Elahi, F. M., et al. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1731306 · Cited by 65
18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome
Cho, H., Baek, M. S., Choi, J. Y., Lee, S. H., Kim, J., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2017) · Neurology · doi:10.1212/wnl.0000000000004364 · Cited by 62
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy
Cali, C. P., Patiño, M., Tai, Y. K., Ho, W. Y., McLean, C., Morris, C. M., Seeley, W. W., Miller, B. L., Gaig, C., Vonsattel, J. P., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02045-5 · Cited by 64
Self-citation
Parkinsonism and Frontotemporal Dementia: The Clinical Overlap
Espay, A. J., & Litvan, I. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9632-1 · Cited by 62
Development and assessment of sensitive immuno‐ PCR assays for the quantification of cerebrospinal fluid three‐ and four‐repeat tau isoforms in tauopathies
Luk, C. Y., Compta, Y., Magdalinou, N. K., Martı́, M. J., Hondhamuni, G., Zetterberg, H., Blennow, K., Constantinescu, R., Pijnenburg, Y. A. L., Mollenhauer, B., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07911.x · Cited by 65
Self-citation
Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
Shin, H., Hong, S.-W., & Youn, Y. C. (2022) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.18.3.259 · Cited by 72
Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome
Sakae, N., Josephs, K. A., Litvan, I., Murray, M. E., Duara, R., Uitti, R. J., Wszołek, Z. K., van Gerpen, J. A., Graff‐Radford, N. R., & Dickson, D. W. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.04.011 · Cited by 66
Clinical Profile of PiB-Positive Corticobasal Syndrome
Burrell, J. R., Hornberger, M., Villemagne, V. L., Rowe, C. C., & Hodges, J. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061025 · Cited by 59
Corticobasal syndrome: A diagnostic conundrum
Parmera, J. B., Rodriguez, R. D., Studart‐Neto, A., Nitríni, R., & Brucki, S. M. D. (2016) · Dementia & Neuropsychologia · doi:10.1590/s1980-5764-2016dn1004003 · Cited by 61
An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease
Uchihara, T. (2016) · Neuropathology · doi:10.1111/neup.12348 · Cited by 55
The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders
Latorre, A., Rocchi, L., Berardelli, A., Bhatia, K., & Rothwell, J. (2019) · Movement Disorders · doi:10.1002/mds.27736 · Cited by 44
The Progressive Supranuclear Palsy Clinical Deficits Scale
Piot, I., Schweyer, K., Respondek, G., Stamelou, M., DescribePSP study group, ProPSP study group, MDS‐endorsed PSP study group, Sckopke, P., Schenk, T., Goetz, C. G., et al. (2020) · Movement Disorders · doi:10.1002/mds.27964 · Cited by 57
Binding characteristics of [ 18 F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
Song, M., Beyer, L., Kaiser, L., Barthel, H., van Eimeren, T., MAREK, K. L., Nitschmann, A., Scheifele, M., Palleis, C., Respondek, G., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211018904 · Cited by 55
Movement disorders: role of imaging in diagnosis
Mascalchi, M., Vella, A., & Ceravolo, R. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22825 · Cited by 53
Clinico-Pathological Correlations of the Most Common Neurodegenerative Dementias
Taipa, R. J. F., Pinho, J., & Pires, M. M. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00068 · Cited by 54
Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
Moda, F., Ciullini, A., Dellarole, I. L., Lombardo, A., Campanella, N., Bufano, G., Cazzaniga, F. A., & Giaccone, G. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810255 · Cited by 49
Fifty years of progressive supranuclear palsy
Colosimo, C., Bak, T. H., Bologna, M., & Berardelli, A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305740 · Cited by 50
New Perspective on Parkinsonism in Frontotemporal Lobar Degeneration
Park, H. K., & Chung, S. J. (2013) · Journal of Movement Disorders · doi:10.14802/jmd.13001 · Cited by 52
The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism
Schottlaender, L., Polke, J. M., Ling, H., MacDoanld, N. D., Tucci, A., Nanji, T., Pittman, A. M., de Silva, R., Holton, J. L., Révész, T., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.024 · Cited by 49
Self-citation
Corticobasal syndrome
Chahine, L. M., Rebeiz, T., Rebeiz, J. J., Grossman, M., & Gross, R. G. (2014) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000026 · Cited by 52
Corticobasal degeneration
Saranza, G., Whitwell, J. L., Kovács, G. G., & Lang, A. E. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.014 · Cited by 52
CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
Constantinides, V. C., Paraskevas, G. P., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Stefanis, L., & Kapaki, E. N. (2023) · Diagnostics · doi:10.3390/diagnostics13040783 · Cited by 53
What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective
Thobois, S., Prange, S., Scheiber, C., & Broussolle, E. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.08.016 · Cited by 51

Authors: Ling, H., O'Sullivan, S. S., Holton, J. L., Revesz, T., Massey, L. A., Williams, D. R., Paviour, D. C., & Lees, A. J.
Affiliations: National Hospital for Neurology and Neurosurgery (GB)
UCL Queen Square Institute of Neurology (GB)
ORCID: Ling, H.
Holton, J. L.
Lees, A. J.
Venue: Brain
Publisher: Oxford University Press (OUP)
Published: 2010-06-28
Volume: 133
Issue: 7
Pages: 2045-2057
ISSN: 0006-8950 (ISSN-L)
1460-2156
DOI: 10.1093/brain/awq123
OpenAlex: W2103019844
Cited by: 394
References: 63
Citations by year: 2026: 13 · 2025: 14 · 2024: 18 · 2023: 16 · 2022: 18 · 2021: 22 · 2020: 25 · 2019: 30 · 2018: 23 · 2017: 33 · 2016: 20 · 2015: 25 · 2014: 38 · 2013: 30 · 2012: 29
FWCI: 21.46
Type: journal article
Language: en
Open access: closed
Locations: Brain (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: corticobasal degeneration, corticobasal syndrome, progressive supranuclear palsy, Richardson's syndrome, misdiagnosis, vertical supranuclear gaze palsy, limb apraxia, myoclonus, limb dystonia
MeSH terms: Aged, Aged, 80 and over, Basal Ganglia, Basal Ganglia Diseases, Cerebral Cortex, Female, Humans, Male, Middle Aged, Retrospective Studies, Supranuclear Palsy, Progressive, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Does corticobasal degeneration exist? A clinicopathological re-evaluation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks